TSS
IMNP

Two Sigma Securities’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Two Sigma Securities’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,975
Closed -$41K – 2138
2017
Q3 		$41K Buy
26,975
+15,062
+126% +$26.3K ﹤0.01% 762
2017
Q2 		$37K Buy
+11,913
New +$32K 0.01% 735
2017
Q1 		– Sell
-7,950
Closed -$29K – 1215
2016
Q4 		$29K Buy
7,950
+6,375
+405% +$26.2K 0.01% 634
2016
Q3 		$9K Buy
+1,575
New +$11.6K ﹤0.01% 632
2015
Q4 		– Sell
-774
Closed -$18K – 399
2015
Q3 		$18K Buy
+774
New +$24.4K 0.03% 182

Other funds holding IMNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Two Sigma Securities's IMNP Position: Q4 2017 in Review

Two Sigma Securities sold out of Immune Pharmaceuticals Inc. (IMNP) in Q4 2017, closing a stake of 26,975 shares — an estimated $41K sold.

Two Sigma Securities first reported a position in IMNP in Q3 2015 and held it in 5 quarters. The position peaked at $41K in Q3 2017. 15 funds tracked by Wall St. Rank hold IMNP as of Q4 2017.

  • Two Sigma Securities reported no remaining Immune Pharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
  • Two Sigma Securities sold 26,975 Immune Pharmaceuticals Inc. shares in Q4 2017, an estimated $41K.
  • Two Sigma Securities first reported a position in Immune Pharmaceuticals Inc. in Q3 2015 and held it in 5 quarters.
  • Two Sigma Securities's Immune Pharmaceuticals Inc. position peaked at $41K in Q3 2017.
  • 15 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2017.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.